Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

    Recruiting

    3 1 1
    France Germany Greece Italy Spain Sweden
  • Study on the Safety and Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Adults with Severe or Moderately Severe Hemophilia B and AAV5 Antibodies

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Poland
  • Study on the Safety and Effectiveness of REGV131 and LNP1265 for Adults with Hemophilia B

    Recruiting

    2 1 1
    France Germany Italy Spain
  • Study on Long-Term Safety and Effects of Marstacimab for Patients with Severe Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Croatia Czechia Denmark France Germany +3
  • Study on Marstacimab for Children with Severe Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Czechia Denmark France Germany Italy +2
  • Study of Etranacogene Dezaparvovec (CSL222) in Adolescent Males with Severe or Moderately Severe Hemophilia B

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Spain
  • Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

    Not yet recruiting

    3 1 1 1
    Bulgaria Croatia Czechia France Hungary Ireland +4
  • Title: Study of gene therapy Etranacogene Dezaparvovec (Hemgenix) in adult patients with moderate to severe Hemophilia B

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Germany Ireland The Netherlands Sweden
  • Long-term Safety Study of Etranacogene Dezaparvovec in Adult Men with Hemophilia B

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Germany Ireland The Netherlands Sweden
  • Study on Long-Term Safety and Efficacy of Etranacogene Dezaparvovec for Adults with Severe or Moderately Severe Hemophilia B

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany The Netherlands